Capsugel’s Dosage Form Solutions (DFS) business unit has upgraded and expanded three of its manufacturing facilities in the U.S. and Europe. The multi-million dollar investments broaden the company’s global capabilities to handle hormonal as well as high-potent compounds for soft gelatin and liquid-fill hard capsules (LFHC), responding to a growing demand from its pharmaceutical and health and nutrition customers. The moves are intended to deepen the company’s finished dosage form capabilities a...